Cardiopulmonary bypass (CPB) results in short-term (3–5 h) exposure to flow with diminished pulsatility often referred to as “continuous flow”. It is unclear if short-term exposure to continuous flow influences endothelial function, particularly, changes in levels of pro-inflammatory and pro-angiogenic cytokines. In this study, we used the endothelial cell culture model (ECCM) to evaluate if short-term (≤5 h) reduction in pulsatility alters levels of pro-inflammatory/pro-angiogenic cytokine levels. Human aortic endothelial cells (HAECs) cultured within the ECCM provide a simple model to evaluate endothelial cell function in the absence of confounding factors. HAECs were maintained under normal pulsatile flow for 24 h and then subjected to continuous flow (diminished pulsatile pressure and flow) as observed during CPB for 5 h. The ECCM replicated pulsatility and flow morphologies associated with normal hemodynamic status and CPB as seen with clinically used roller pumps. Levels of angiopoietin-2 (ANG-2), vascular endothelial growth factor-A (VEGF-A), and hepatocyte growth factor were lower in the continuous flow group in comparison to the pulsatile flow group whereas the levels of endothelin-1 (ET-1), granulocyte colony stimulating factor, interleukin-8 (IL-8) and placental growth factor were higher in the continuous flow group in comparison to the pulsatile flow group. Immunolabelling of HAECs subjected to continuous flow showed a decrease in expression of ANG-2 and VEGF-A surface receptors, tyrosine protein kinase-2 and Fms-related receptor tyrosine kinase-1, respectively. Given that the 5 h exposure to continuous flow is insufficient for transcriptional regulation, it is likely that pro-inflammatory/pro-angiogenic signaling observed was due to signaling molecules stored in Weible-Palade bodies (ET-1, IL-8, ANG-2) and via HAEC binding/uptake of soluble factors in media. These results suggest that even short-term exposure to continuous flow can potentially activate pro-inflammatory/pro-angiogenic signaling in cultured HAECs and pulsatile flow may be a successful strategy in reducing the undesirable sequalae following continuous flow CPB.

1.
Alkan-Bozkaya
T
,
Akçevin
A
,
Türkoğlu
H
,
Ündar
A
.
Impact of pulsatile perfusion on clinical outcomes of neonates and infants with complex pathologies undergoing cardiopulmonary bypass procedures
.
Artif Organs
.
2013
;
37
(
1
):
82
6
.
2.
Balcioglu
O
,
Engin
C
,
Yagdi
T
,
Nalbantgil
S
,
Baysal
B
,
Erkul
S
,
Effect of aortic valve movements on gastrointestinal bleeding that occured in continuous flow left ventricular assist device patients
.
Transplant Proc
.
2013
;
45
(
3
):
1020
1
.
3.
Bishop
H
,
Middleton
B
.
Cardiopulmonary bypass
.
Surgery (Oxford)
.
2018
;
36
(
2
):
63
7
.
4.
Clarke
CP
,
Kahn
DR
,
Dufek
JH
,
Sloan
H
.
The effects of nonpulsatile blood flow on canine lungs
.
Ann Thorac Surg
.
1968
;
6
(
5
):
450
7
.
5.
Edmunds
LH
 Jr
.
The evolution of cardiopulmonary bypass: lessons to be learned
.
Perfusion
.
2002
;
17
(
4
):
243
51
.
6.
Gabe
IT
,
Gault
JH
,
Ross
J
,
Mason
DT
,
Mills
CJ
,
Schillingford
JP
,
Measurement of Instantaneous Blood Flow Velocity and Pressure in Conscious Man with a Catheter-Tip Velocity Probe
.
Circulation
.
1969
;
40
(
5
):
603
14
.
7.
Gaer
JA
,
Shaw
AD
,
Wild
R
,
Swift
RI
,
Munsch
CM
,
Smith
PL
,
Effect of cardiopulmonary bypass on gastrointestinal perfusion and function
.
Ann Thorac Surg
.
1994
;
57
(
2
):
371
5
.
8.
Gravlee
GP
,
Davis
RF
,
Stammers
AH
,
Ungerleider
RM
, editors.
Cardiopulmonary bypass: principles and practice
. 3rd.
Philadelphia
:
Lippincott Williams & Wilkins
;
2008
.
9.
Haglund
NA
,
Davis
ME
,
Tricarico
NM
,
Keebler
ME
,
Maltais
S
.
Readmissions after continuous flow left ventricular assist device implantation: differences observed between two contemporary device types
.
ASAIO J
.
2015
;
61
(
4
):
410
6
.
10.
Haglund
TA
,
Rajasekaran
NS
,
Smood
B
,
Giridharan
GA
,
Hoopes
CW
,
Holman
WL
,
Evaluation of flow-modulation approaches in ventricular assist devices using an in-vitro endothelial cell culture model
.
J Heart Lung Transplant
.
2019
;
38
(
4
):
456
65
.
11.
Huang
RJ
,
Wong
RJ
,
Draper
KV
,
Winter
TA
.
De novo arteriovenous malformations following implantation of the HeartMate II left ventricular assist device
.
Endoscopy
.
2012
;
44
(
Suppl 2
):
E441
.
UCTN
.
12.
Jabbar
HR
,
Abbas
A
,
Ahmed
M
,
Klodell
CT
,
Chang
M
,
Dai
Y
,
The incidence, predictors and outcomes of gastrointestinal bleeding in patients with left ventricular assist device (LVAD)
.
Dig Dis Sci
.
2015
;
60
(
12
):
3697
706
.
13.
Jacobs
JP
,
O’Brien
SM
,
Pasquali
SK
,
Gaynor
JW
,
Mayer
JE
 Jr
,
Karamlou
T
,
The Society of Thoracic Surgeons congenital heart surgery database mortality risk model: Part 2—clinical application
.
Ann Thorac Surg
.
2015
;
100
(
3
):
1063
8
.
14.
Kamdar
F
,
Boyle
A
,
Liao
K
,
Colvin-adams
M
,
Joyce
L
,
John
R
.
Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients
.
J Heart Lung Transplant
.
2009
;
28
(
4
):
352
9
.
15.
Kato
TS
,
Chokshi
A
,
Singh
P
,
Khawaja
T
,
Cheema
F
,
Akashi
H
,
Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling
.
Circ Heart Fail
.
2011
;
4
(
5
):
546
53
.
16.
Kim
HK
,
Son
HS
,
Fang
YH
,
Park
SY
,
Hwang
CM
,
Sun
K
.
The effects of pulsatile flow upon renal tissue perfusion during cardiopulmonary bypass: A comparative study of pulsatile and nonpulsatile flow
.
ASAIO J
.
2005
;
51
(
1
):
30
6
.
17.
Kim
I
,
Moon
SO
,
Han
CY
,
Pak
YK
,
Moon
SK
,
Kim
JJ
,
The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis
.
Cardiovasc Res
.
2001
;
49
(
4
):
872
81
.
18.
Kocakulak
M
,
Kuçukaksu
S
,
Piskin
E
.
Pulsatile roller pump perfusion is safe in high risk patients
.
Int J Artif Organs
.
2004
;
27
(
5
):
433
439
. .
19.
Koning
NJ
,
Vonk
AB
,
van Barneveld
LJ
,
Beishuizen
A
,
Atasever
B
,
van den Brom
CE
,
Pulsatile flow during cardiopulmonary bypass preserves postoperative microcirculatory perfusion irrespective of systemic hemodynamics
.
J Appl Physiol
.
2012
;
112
(
10
):
1727
34
.
20.
Lalonde
SD
,
Alba
AC
,
Rigobon
A
,
Ross
HJ
,
Delgado
DH
,
Billia
F
,
Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD
.
J Card Surg
.
2013
;
28
(
5
):
604
10
.
21.
Levine
FH
,
Phillips
HR
,
Carter
JE
,
Philbin
DM
,
Osbakken
MD
,
Boucher
CA
,
The effect of pulsatile perfusion on preservation of left ventricular function after aortocoronary bypass grafting
.
Circulation
.
1981
;
64
(
2 Pt 2
):
ll40
4
.
22.
Loutzenhiser
R
,
Griffin
K
,
Williamson
G
,
Bidani
A
.
Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms
.
Am J Physiol Regul Integr Comp Physiol
.
2006
;
290
(
5
):
R1153
67
.
23.
Madhavan
S
,
Chan
SP
,
Tan
WC
,
Eng
J
,
Li
B
,
Luo
HD
,
Cardiopulmonary bypass time: every minute counts
.
J Cardiovasc Surg (Torino)
.
2018
;
59
(
2
):
274
81
.
24.
Mamikonian
LS
,
Mamo
LB
,
Smith
PB
,
Koo
J
,
Lodge
AJ
,
Turi
JL
.
Cardiopulmonary bypass is associated with hemolysis and acute kidney injury in neonates, infants, and children*
.
Pediatr Crit Care Med
.
2014
;
15
(
3
):
e111
.
25.
Miyamoto
T
,
Karimov
JH
,
Fukamachi
K
.
Effects of continuous and pulsatile flows generated by ventricular assist devices on renal function and pathology
.
Expert Rev Med Devices
.
2018
;
15
(
3
):
171
82
.
26.
Mori
A
,
Tabata
R
,
Nakamura
Y
,
Watanabe
K
,
Onoe
M
,
Okada
Y
.
Effects of pulsatile cardiopulmonary bypass on carbohydrate and lipid metabolism
.
J Cardiovasc Surg (Torino)
.
1987
;
28
(
6
):
621
6
.
27.
Nagaoka
H
,
Innami
R
,
Watanabe
M
,
Satoh
M
,
Murayama
F
,
Funakoshi
N
.
Preservation of pancreatic beta cell function with pulsatile cardiopulmonary bypass
.
Ann Thorac Surg
.
1989
;
48
(
6
):
798
802
.
28.
O’Brien
SM
,
Jacobs
JP
,
Pasquali
SK
,
Gaynor
JW
,
Karamlou
T
,
Welke
KF
,
The society of thoracic surgeons congenital heart surgery database mortality risk model: part 1—statistical methodology
.
Ann Thorac Surg
.
2015
;
100
(
3
):
1054
62
.
29.
O’Neil
MP
,
Rene
A
,
Guo
LR
,
Myers
ML
,
Murkin
JM
,
Ellis
CG
.
Microvascular responsiveness to pulsatile and nonpulsatile flow during cardiopulmonary bypass
.
Ann Thorac Surg
.
2018
;
105
(
6
):
1745
1753
. .
30.
Ooka
T
,
Matsui
Y
.
Optimal timing of left ventricular assist device implantation for severe heart failure patients: focus on end-organ function not hemodynamics
.
Circ J
.
2012
;
76
(
7
):
1587
8
.
31.
Parichehreh
V
,
Medepallai
K
,
Babbarwal
K
,
Sethu
P
.
Microfluidic inertia enhanced phase partitioning for enriching nucleated cell populations in blood
.
Lab Chip
.
2013
;
13
(
5
):
892
900
.
32.
Patibandla
PK
,
Rajasekaran
NS
,
Shelar
SB
,
Giridharan
GA
,
Litovsky
SH
,
Sethu
P
.
Evaluation of the effect of diminished pulsatility as seen in continuous flow ventricular assist devices on arterial endothelial cell phenotype and function
.
J Heart Lung Transplant
.
2016
;
35
(
7
):
930
2
.
33.
Purohit
SN
,
Cornwell
WK
 III
,
Pal
JD
,
Lindenfeld
J
,
Ambardekar
AV
.
Living without a pulse: the vascular implications of continuous-flow left ventricular assist devices
.
Circ Heart Fail
.
2018
;
11
(
6
):
e004670
.
34.
Rangasamy
S
,
Madan
S
,
Saeed
O
,
Goldstein
DJ
,
Jorde
UP
,
Negassa
A
,
Noninvasive measures of pulsatility and blood pressure during continuous-flow left ventricular assist device support
.
ASAIO J
.
2019
;
65
(
3
):
241
6
.
35.
Ray
R
,
Kale
PP
,
Ha
R
,
Banerjee
D
.
Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide
.
ASAIO J
.
2014
;
60
(
4
):
482
3
.
36.
Sakaguchi
M
,
Kitagawa
K
,
Okazaki
S
,
Yoshioka
D
,
Sakata
Y
,
Mochizuki
H
,
Sulcus subarachnoid hemorrhage is a common stroke subtype in patients with implanted left ventricular assist devices
.
Eur J Neurol
.
2015
;
22
(
7
):
1088
.
37.
Sarkar
M
,
Prabhu
V
.
Basics of cardiopulmonary bypass
.
Indian J Anaesth
.
2017
;
61
(
9
):
760
.
38.
Sawano
A
,
Iwai
S
,
Sakurai
Y
,
Ito
M
,
Shitara
K
,
Nakahata
T
,
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans
.
Blood
.
2001
;
97
(
3
):
785
91
.
39.
Slaughter
MS
,
Rogers
JG
,
Milano
CA
,
Russell
SD
,
Conte
JV
,
Feldman
D
,
Advanced heart failure treated with continuous-flow left ventricular assist device
.
N Engl J Med
.
2009
;
361
(
23
):
2241
51
.
40.
Stansfield
WE
,
Rao
V
.
HeartMate 3: Facing the challenge of past success
.
J Thorac Cardiovasc Surg
.
2016
;
152
(
3
):
683
5
.
41.
Thohan
V
,
Stetson
SJ
,
Nagueh
SF
,
Rivas-Gotz
C
,
Koerner
MM
,
Lafuente
JA
,
Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices
.
J Heart Lung Transplant
.
2005
;
24
(
5
):
566
75
.
42.
Undar
A
,
Masai
T
,
Yang
SQ
,
Eichstaedt
HC
,
McGarry
MC
,
Vaughn
WK
,
Global and regional cerebral blood flow in neonatal piglets undergoing pulsatile cardiopulmonary bypass with continuous perfusion at 25 degrees C and circulatory arrest at 18 degrees C
.
Perfusion
.
2001
;
16
(
6
):
503
10
.
43.
Ündar
A
,
Masai
T
,
Beyer
EA
,
Goddard-Finegold
J
,
McGarry
MC
,
Fraser
CD
 Jr
.
Pediatric physiologic pulsatile pump enhances cerebral and renal blood flow during and after cardiopulmonary bypass
.
Artif Organs
.
2002
;
26
(
11
):
919
23
.
44.
Valentijn
KM
,
Sadler
JE
,
Valentijn
JA
,
Voorberg
J
,
Eikenboom
J
.
Functional architecture of Weibel-Palade bodies
.
Blood
.
2011
;
117
(
19
):
5033
43
.
45.
Wang
Y
,
Bellomo
R
.
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
.
Nat Rev Nephrol
.
2017
;
13
(
11
):
697
.
46.
Wheeldon
DR
,
Bethune
DW
,
Gill
RD
.
Vortex pumping for routine cardiac surgery: a comparative study
.
Perfusion
.
1990
;
5
(
2
):
135
43
.
47.
Zhang
Y
,
Kontos
CD
,
Annex
BH
,
Popel
AS
.
Angiopoietin-Tie signaling pathway in endothelial cells: a computational model
.
iScience
.
2019
;
20
:
497
511
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.